Our new publication in JACC helps to optimize ADMERA Health’s CardioGxOne™ test

A new article written by the team of HIC published in The Journal of the American College of Cardiology (JACC) has helped to increase mutation detection rates of Admera Health’s CardioGxOne™ test. Thanks to the addition of the FLNC gene to the main panel, they will be able to evaluate patients with high-risk dilated and arrhythmogenic cardiomyopathies more effectively.

Link to the article: https://www.pm360online.com/category/nasdaq/nasdaq-cardiology-market-news/

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

Aviso de cookies